Close
Greenfire Resources Announces Participation in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 May 23, 2024 05:29PM

Calgary, Alberta--(Newsfile Corp. - May 23, 2024) - Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the sustainable production and development of thermal energy resources from the Athabasca region of Alberta, Canada, is pleased to announce that Greenfire will give a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2024 Investor Conference, taking place... (continue reading...)


WASTE MANAGEMENT TEAMSTERS RATIFY CONTRACT May 23, 2024 05:30PM

Local 533 Members Win Significant Pay Increases, Improved Benefits

RENO, Nev., May 23, 2024 /PRNewswire/ -- Members of Teamsters Local 533 have overwhelmingly ratified a new five-year collective bargaining agreement with Waste Management. The contract covers over 250 workers who service the communities of Lyon, Storey, and Washoe counties.

"I want to... (continue reading...)


Sapience Therapeutics to Showcase Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 May 23, 2024 05:30PM

-Oral presentation on June 1, 2024-

TARRYTOWN, N.Y., May 23, 2024 /PRNewswire/ -- Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, today announced that clinical and biomarker data from its ST101 Phase 2 study in GBM will be delivered during an oral presentation on June 1, 2024 at the upcoming 2024 American Society of... (continue reading...)


Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting May 23, 2024 05:30PM

nab-Sirolimus demonstrated significantly greater intratumoral drug concentration, stronger inhibition of mTOR targets and greater antitumor activity compared to IV and oral mTOR inhibitors in a xenograft model

Data support further clinical exploration of nab-sirolimus as a single agent or in combination

LOS ANGELES, May 23, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and... (continue reading...)


Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting May 23, 2024 05:30PM
  • ELI-002 7P administered as a monotherapy was well tolerated and able to generate a ~100x mKRAS-specific expanded T cell response relative to baseline levels
  • ELI-002 7P generated an mKRAS-specific T cell response in 100% of patients including responses targeting all mKRAS mutations enrolled (G12D, V, R and G13D)
  • mKRAS-specific T cells were polyfunctional with 66.7% (4/6) of evaluable patients having both CD8+ and CD4+ responses at the 4.9 mg Phase 2 dose level
  • Tumor... (continue reading...)

More Press Releases

View Older Stories

May 23, 2024 05:30PM Power Integrations to Present at Upcoming Investor Conferences
May 23, 2024 05:30PM Premier Health Reports 2024 Second Quarter Results
May 23, 2024 05:30PM Titanium Transportation Group Declares Quarterly Dividend
May 23, 2024 05:29PM ALT Stockholders: Robbins LLP Reminds ALT Stockholders of Securities Fraud Class Action Against Altimmune, Inc.
May 23, 2024 04:50PM Community Bancorp. Re-Elects Directors and Discusses Strong 2023 and First Quarter 2024 Results at Annual Shareholders' Meeting
May 23, 2024 05:27PM EDETEK Launches Continuous Study Monitoring Module for CONFORM™ Informatics
May 23, 2024 05:01PM CXApp Inc. (Nasdaq: CXAI) Announces Record NRR Growth for Q1’24 & Launch of CXAI VU in collaboration with Google Cloud
May 23, 2024 05:25PM MTTR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Matterport to CoStar Group
May 23, 2024 05:25PM MTTR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Matterport to CoStar Group
May 23, 2024 05:25PM SSR Mining Announces Voting Results From 2024 Annual and Special Meeting of Shareholders
May 23, 2024 05:23PM Tiny Announces Annual General and Special Meeting of Shareholders
May 23, 2024 05:23PM Pan American Silver Releases 2023 Sustainability Report
May 23, 2024 05:22PM HRBR Stockholders: Robbins LLP Reminds HRBR Stockholders of Securities Fraud Class Action Against Harbor Diversified, Inc.
May 23, 2024 05:23PM DOCS INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
May 23, 2024 05:22PM Trailblazing Dragons' Den Star Named United Nations Association in Canada's 2024 Global Citizen Laureate
May 23, 2024 05:21PM INTC Stockholders: Robbins LLP Reminds INTC Stockholders of Securities Fraud Class Action Against Intel Corporation
May 23, 2024 05:21PM Graphic Packaging Holding Company Declares Quarterly Dividend
May 23, 2024 05:21PM Crypto Specialist Bitwise’s First-Ever Spot Ethereum ETF Receives Key SEC Approval
May 23, 2024 05:20PM Sailfish Reports Q1 2024 Results
May 23, 2024 05:20PM Gesa Credit Union Announces Agreement to Acquire Security State Bank
May 23, 2024 05:19PM EDETEK to Showcase "End-to-End Digital Data Pipeline for Clinical Trials" at AWS Healthcare and Life Sciences Meetup in Los Angeles, CA
May 23, 2024 05:20PM Pei enters the MSCI COLCAP index
May 23, 2024 05:18PM Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
May 23, 2024 05:18PM Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
May 23, 2024 05:18PM NextEra Energy board declares quarterly dividend
May 23, 2024 05:18PM Oklo Partners with Wyoming Hyperscale to Deliver 100 Megawatts to its Data Centers
May 23, 2024 05:15PM American Aires Extends Global Expansion by Opening Latest International Fulfillment Center in the UK
May 23, 2024 05:15PM Deveron Announces Dates for Q3 2024 Earnings Release
May 23, 2024 05:15PM Aurania Announces Closing of Tranche 2 of Private Placement
May 23, 2024 06:09PM Avenix Fzco Introduces New Expert Advisor Pivozon for Enhanced Forex Trading on EURUSD
May 23, 2024 05:15PM Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting
May 23, 2024 05:15PM Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2024 Annual Meeting
May 23, 2024 05:15PM PARAMOUNT GLOBAL AND CHARTER COMMUNICATIONS ANNOUNCE NEW MULTI-YEAR AGREEMENT FOR DISTRIBUTION OF PARAMOUNT'S LINEAR NETWORKS, CBS OWNED-AND-OPERATED STATIONS AND DIRECT-TO-CONSUMER STREAMING SERVICES
May 23, 2024 05:15PM NW Natural Holdings and NW Natural CEO David H. Anderson Announces Retirement
May 23, 2024 05:15PM Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:13PM SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:12PM SILVERCORP REPORTS ADJUSTED NET INCOME OF $39.3 MILLION, $0.22 PER SHARE, AND CASH FLOW FROM OPERATIONS OF $91.6 MILLION FOR FISCAL 2024
May 23, 2024 05:12PM Nimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual Meeting
May 23, 2024 05:11PM Special Olympics Florida and Orlando Health Announce Five-Year Partnership
May 23, 2024 05:10PM Extraordinary 80+ Acre Paradise Island, Boca Grande, FL, Hits Market After 70-Years: A Once-in-a-Lifetime Opportunity for Discerning Buyers
May 23, 2024 05:10PM Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
May 23, 2024 05:10PM Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
May 23, 2024 05:10PM Barnes & Noble Education Announces Preliminary Fiscal Year 2024 Results
May 23, 2024 05:09PM Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
May 23, 2024 05:09PM KinderCare Learning Companies Applauds Bipartisan Effort to Support Working Families through Child Care Access
May 23, 2024 05:06PM G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
May 23, 2024 05:05PM Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
May 23, 2024 05:05PM EpicentRx Announces Oral Presentation for the Most Clinically Advanced TGF-β Ligand Trap, AdAPT-001, at the Upcoming 2024 ASCO Annual Meeting
May 23, 2024 05:05PM Landmark Study from Mercy BioAnalytics and University College London Demonstrates Significant Improvement Over CA125 and Ultrasound for Ovarian Cancer Screening
May 23, 2024 05:05PM FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer (m
View Older Stories